QQ客服 官方微博 反馈留言

	Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout
	Zhen, Shuai; Lu, Jiaojiao; Chen, Wei; Zhao, Le; Li, Xu
刊名	HUMAN GENE THERAPY
	2018
卷号	29页码:1352-1363
关键词	LncRNA targeted therapy checkpoint blockade PD-1 combination therapy
ISSN号	1043-0342
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2921643
专题	西安交通大学
推荐引用方式 GB/T 7714	Zhen, Shuai,Lu, Jiaojiao,Chen, Wei,et al. Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout[J]. HUMAN GENE THERAPY,2018,29:1352-1363.
APA	Zhen, Shuai,Lu, Jiaojiao,Chen, Wei,Zhao, Le,&Li, Xu.(2018).Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout.HUMAN GENE THERAPY,29,1352-1363.
MLA	Zhen, Shuai,et al."Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout".HUMAN GENE THERAPY 29(2018):1352-1363.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。